Laxmi Dental Limited (LAXMIDENTL)

Loading page…

Laxmi Dental Limited (LAXMIDENTL) · mywealthgrid

About

Laxmi Dental supplies medical equipment and devices in healthcare, operating at ₹1,110 Cr market cap through standalone and consolidated subsidiaries. Core standalone business holds 15–16% operating margins; consolidated operations reach 19% OPM, positioning the company in India's medical-equipment supply chain with a functional dual-segment structure.

Face value: ₹2

Market cap

₹1,066 Cr

P/E

34.5×

P/B

4.4×

Dividend yield

ROE

12.8%

ROCE

14.7%

Debt / equity

OPM

15.6%

EPS (TTM)

₹5.6

Book value

₹44.3

52-week high

—

52-week low

Key insights

Company research notes and source-linked reviews

Key risks

Stock down 49.62% YoY and crashed from ₹395.6 52w high to ₹202, indicating sustained value erosion and acute volatility.
Standalone operating margin collapsed to 9.41% (Dec 2025) with net loss of ₹1.89 Cr same quarter, while consolidated turned ₹1.96 Cr profit—opaque group structure masks whether subsidiary propping up core business weakness.
PE of 35.93× trades at premium to ROE of 12.83%, leaving stock vulnerable to earnings disappointment or valuation reset.
Standalone segment margins ranged 9.41%–16.05% across four quarters, indicating unpredictable profitability that researchers should audit for root cause (demand, pricing, cost, or cyclical trough).

Generated analysis · source review pending

Growth drivers

Consolidated operations at 19.24% OPM (Jun 2026) outpace standalone 16.05%, with consolidated revenue (₹74.7 Cr) consistently exceeding standalone (₹55.2 Cr)—scaling this margin-accretive segment could improve group returns.
Profitability rebounded across three quarters after Dec 2025 standalone loss; researcher should verify whether recovery reflects cyclical trough or structural improvement in product mix or cost structure.
Medical equipment sector tied to Indian healthcare capex cycles—researcher should verify sector growth rate and whether Laxmi Dental is gaining share or defending position.
FII holding at 30.1% alongside promoter 41.8% signals institutional conviction; researcher should verify what fundamentals justify this backing relative to 49% stock decline.

Generated analysis · source review pending

417 historical price candles were omitted because the exchange source has not been verified.

₹193.9+0.7%1Y

Quick read

rule-based

Pros

+Strong return on equity of 32.5% (3-yr avg)
+Almost debt-free (debt/equity 0)
+Comfortable interest coverage of 26.3×

Cons

No red flags triggered.

Research score

Structured signal from quality, growth, valuation and momentum.

59/100

Business quality: 60
Growth: 73
Valuation: 45

Revenue & net profit

₹ crore, by fiscal year

RevenuePAT

Margins

% of revenue, by fiscal year

OPMPAT margin

Peers

Comparable companies from the narrowest available industry classification.

Screen this industry

Loading peers…

Financials

Reported profit and loss, balance sheet, cash flow and growth history.

Annual Quarterly

Consolidated Standalone

Consolidated figures · ₹ crore

₹ Cr	Mar 2024	Mar 2025	Mar 2026
	194	239	278
COGS	49	57	82
Gross profit	145	182	196
	121	133	150
	24	49	46
OPM %	12.3%	20.5%	16.5%
Depreciation	12	15	16
Interest	5	5	1
	2	10	3
Profit before tax	16	38	31
Tax	-9	6	3
Tax %	-59.6%	16.9%	8%
	25	32	29
PAT margin %	13%	13.3%	10.4%
EPS (₹)	—	6.1	5.5
EPS adjusted (₹)	162.8	5.8	5.3
Annual report	—	Annual report for Mar 2025	—

₹ Cr	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity capital	0	0	11	11
Reserves	—	42	198	232
Minority interest	—	2	0	1
	—	42	11	0
	—	48	65	50
Total equity & liabilities	—	135	285	294
	39	45	51	63
CWIP	—	—	—	0
Investments	—	6	10	27
	—	83	224	204
Total assets	—	135	285	294

₹ Cr	Mar 2024	Mar 2025	Mar 2026
	8	44	-5
	-11	-29	-80
	-3	111	-18
Net cash flow	-5	125	-102
Free cash flow	-6	29	-21
CFO / Operating profit %	34.3%	104.7%	-11.5%

Compounded sales growth

7 years: —
5 years: —
3 years: —
1 year: 16%

Compounded profit growth

7 years: —
5 years: —
3 years: —
1 year: -9%

Return on equity

7 years: —
5 years: —
3 years: 28%
Last year: 12%

Segment results

As reported in NSE results XBRL. Segment result is before tax and finance costs.

Source XBRL ↗

Latest reported period · 31 Mar 2026 · ₹ crore

Segment	Revenue	Result	Assets	Liabilities
Laboratory Business	196.87	30.19	0	0
Aligners Business	76.65	14.44	0	0
Other business	8.64	-1.23

Loading financials…

Ratios

Annual operating, return, leverage and working-capital ratios.

Consolidated Standalone

Consolidated figures

Ratio	Mar 2024	Mar 2025	Mar 2026
Margins
Gross margin %	74.9%	76.1%	70.4%
EBITDA margin %	12.3%	17.5%	15.6%
EBIT margin %	6.1%	11.2%	9.9%
PAT margin %	13%	13.3%	10.4%
Working capital
Receivable days	47	56	60
Inventory days	186	119	97
Payable days	119	204	47
NWC days	114	-30	109
Leverage
Current ratio	0.96	3.3	6.21
Debt to EBITDA	1.77	0.27	0
Debt to equity	0.99	0.05	0
Interest coverage	2.7	5.6	26.3
Asset turnover	1.44	0.84	0.95
Return ratios
Return on assets %	18.8%	11.2%	9.8%
Return on capital employed %	20.1%	20.4%	14.7%
Return on equity %	59.4%	15.3%	11.9%

Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.

Loading ratios…

Shareholding

Quarterly ownership, named holders, insider transactions and disclosed deals.

Quarterly Annual

Every quarter filed · % of equity

Holder (%)	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	41.7%	41.7%	41.7%	41.7%	41.7%	41.77%	41.8%
	29.49%	34.24%	33.59%	32.39%	32.45%	31.21%	30.1%
	15.18%	12.86%	14.31%	11.85%	10.83%	10.52%	10.89%
Government	0%	0%	0%	0%	0%	0%	0%
	13.63%	11.2%	10.4%	14.06%	15.02%	16.5%	17.21%
No. of shareholders	—	—	—	37,909	38,635	38,161	36,937

Promoter holding up 0.1 percentage points since Dec 2024.

77 deals · 20 Jan 2025 – 22 May 2026

Date	Client	Type	Venue	Side	Quantity	Price	Value
22 May 2026	NEO APEX SHARE BROKING SERVICES LLP	Bulk	NSE	Buy	3,42,346	₹247.65	₹8.48 Cr
22 May 2026	NEO APEX SHARE BROKING SERVICES LLP	Bulk	NSE	Sell	3,42,346	₹249.28	₹8.53 Cr
22 May 2026	MANSI SHARE AND STOCK BROKING PRIVATE LIMITED	Bulk	NSE	Sell	2,78,074	₹249.28	₹6.93 Cr
22 May 2026	MANSI SHARE AND STOCK BROKING PRIVATE LIMITED	Bulk	NSE	Buy	2,78,074	₹248.94	₹6.92 Cr
19 Feb 2026	NK SECURITIES RESEARCH PRIVATE LIMITED	Bulk	NSE	Sell	5,26,205	₹203.11	₹10.69 Cr
19 Feb 2026	NK SECURITIES RESEARCH PRIVATE LIMITED	Bulk	NSE	Buy	5,26,205	₹202.93	₹10.68 Cr
17 Sept 2025	GRAVITON RESEARCH CAPITAL LLP	Bulk	NSE	Sell	6,82,079	₹360.98	₹24.62 Cr
17 Sept 2025	GRAVITON RESEARCH CAPITAL LLP	Bulk	NSE	Buy	6,82,079	₹361.45	₹24.65 Cr
17 Sept 2025	HRTI PRIVATE LIMITED	Bulk	NSE	Buy	4,28,476	₹360.14	₹15.43 Cr
17 Sept 2025	HRTI PRIVATE LIMITED	Bulk	NSE	Sell	4,15,826	₹360.88	₹15.01 Cr

1–10 of 77

1 / 8

Mr. RAJESH VRAJLAL KHAKHARExecutive Director-Chairperson related to Promoter
Mr. SAMEER KAMLESH MERCHANTExecutive Director-CEO-MD
Mr. ANIL TILAKRAJ ARORANon-Executive - Non Independent Director
Mr. RAJESH SHASHIKANT DALALNon-Executive - Independent Director
Mrs. ANJANA GREWALNon-Executive - Independent Director
Mr. DEVESH GHANSHYAM CHAWLANon-Executive - Independent Director
Mr. Suman SahaCompany Secretary & Compliance Officer

Current officeholders as filed with BSE. A person holding two offices is listed once per office.

Loading shareholding…

F&O

Current futures and options contracts with compact option-chain pages.

Not in the F&O segment

Only about 210 stocks have listed futures and options. Contracts appear here for those, refreshed after each close.

Loading f&o…

Fund holders

Mutual-fund schemes that disclosed a holding in the company.

Portfolio month

Schemes holding

across 6 fund houses

Held by these funds

6.46%

of the company's equity

All mutual funds

10.11%

shareholding pattern, Jun 2026

Portfolios as of

August 2026

compared with July 2026

9 schemes · 6 fund houses

		Shares
Healthcare FundNEW	ICICI Prudential Mutual Fund	23.96 L	46.84	0.67%	4.357%	—
SMALL CAP FUND	Bank of India Mutual Fund	4.53 L	8.85	0.27%	0.823%	-0
Healthcare Fund	DSP Mutual Fund	2.8 L	5.48	0.14%	0.51%	-0
ELSS - TAX SAVER FUNDNEW	Tata Mutual Fund	2.8 L	5.48	0.12%	0.51%	—
Portfolio of Kotak Healthcare Fund	Kotak Mahindra Mutual Fund	65,186	1.27	0.17%	0.119%	-1.39 L
INDIA INNOVATION FUND	Tata Mutual Fund	50,251	0.98	0.07%	0.091%	-0
Exports and Services Fund	ICICI Prudential Mutual Fund	25,844	0.51	0.03%	0.047%	-2.76 L
Conservative Hybrid Fund	Bank of India Mutual Fund	4,000	0.08	0.12%	0.007%	-0

1–8 of 9

1 / 2

Loading fund holders…

Documents

Annual reports, exchange filings, offer documents, ratings and earnings-call material.

Announcements

Annual reports

Annual Report FY2025from bse Summary

Investor Presentation and earnings call

Aug 2026Transcript AI Summary PPTREC
May 2026Transcript AI Summary PPT

Documents link to external sources (exchange filings, company investor pages).

Loading documents…

Events

Upcoming dates and the company’s corporate-action history.

1

Board meeting to consider results11 Aug 2026

Loading events…

Announcements

Latest exchange announcements, filings and downloadable documents.

1 month 3 months 6 months 1 year All

8 announcementsExport CSV

29 Sept 2026, 7:49 pmAGM/EGM

Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

AGM PDF

18 Sept 2026, 12:02 pmCompany Update

Intimation Of Approval For Listing And Trading Of Further Issue Of Equity Shares Under Laxmi Dental Employee Stock Option Scheme 2024

General PDF

4 Sept 2026, 6:43 pmCompany Update

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Analyst / Investor Meet PDF

4 Sept 2026, 1:37 pmCompany Update

Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper Publication PDF

3 Sept 2026, 9:20 pmOthers

Reg. 34 (1) Annual Report.

Reg. 34 (1) Annual Report PDF

3 Sept 2026, 9:04 pmAGM/EGM

Intimation Of 22Nd Annual General Meeting ('AGM') Scheduled To Be Held On Friday, September 25, 2026

AGM PDF

3 Sept 2026, 1:13 pmCompany Update

Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper Publication PDF

2 Sept 2026, 6:47 pmCompany Update

Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper Publication PDF

Date	Category	Subject	Filing
29 Sept 2026, 7:49 pm	AGM/EGM AGM	Shareholder Meeting / Postal Ballot-Scrutinizer''s Report	PDF
18 Sept 2026, 12:02 pm	Company Update General	Intimation Of Approval For Listing And Trading Of Further Issue Of Equity Shares Under Laxmi Dental Employee Stock Option Scheme 2024

Loading announcements…

Ratio	Mar 2024	Mar 2025	Mar 2026
Margins
Gross margin %	74.9%	76.1%	70.4%
EBITDA margin %	12.3%	17.5%	15.6%
EBIT margin %	6.1%	11.2%	9.9%
PAT margin %	13%	13.3%	10.4%
Working capital
Receivable days	47	56	60
Inventory days	186	119	97
Payable days	119	204	47
NWC days	114	-30	109
Leverage
Current ratio	0.96	3.3	6.21
Debt to EBITDA	1.77	0.27	0
Debt to equity	0.99	0.05	0
Interest coverage	2.7	5.6	26.3
Asset turnover	1.44	0.84	0.95
Return ratios
Return on assets %	18.8%	11.2%	9.8%
Return on capital employed %	20.1%	20.4%	14.7%
Return on equity %	59.4%	15.3%	11.9%

Company	Mkt Cap	EV	Revenue	EBITDA	OPM	PAT	NPM	ROCE	ROE	WC Days
Molbio Diagnostics LimitedMOLBIOMOLBIO	₹17,431 Cr	₹17,844 Cr	₹1,020 Cr	₹262 Cr	25.7%	₹145 Cr	13.6%	23.7%	16.2%	—
Poly Medicure LimitedPOLYMEDPOLYMED	₹16,610 Cr	₹16,952 Cr	₹1,997 Cr	₹461 Cr	23.6%	₹315 Cr	17.1%	14.5%	11%	294
Fischer Medical Ventures LimitedFISCHERFISCHER	₹2,190 Cr	₹2,262 Cr	₹367 Cr	₹50 Cr	14%	₹30 Cr	10.1%	13.6%	8.6%	111
Tarsons Products LimitedTARSONSTARSONS	₹1,752 Cr	₹2,135 Cr	₹441 Cr	₹119 Cr	27.9%	₹11 Cr	3.4%	5%	2.3%	361
Laxmi Dental LimitedLAXMIDENTLLAXMIDENTL	₹1,066 Cr	₹1,066 Cr	₹287 Cr	₹46 Cr	15.6%	₹31 Cr	10.4%	14.7%	12.8%	109
Hemant Surgical Industries LtdHSILHSIL	₹885 Cr	—	₹232 Cr	₹23 Cr	10%	₹18 Cr	7.9%	—	—	—
Fabtech Technologies LimitedFABTECHFABTECH	₹632 Cr	₹675 Cr	₹418 Cr	₹45 Cr	8.5%	₹49 Cr	9.3%	15.5%	12.9%	55
Prevest Denpro LtdPREVESTPREVEST	₹452 Cr	—	₹72 Cr	₹25 Cr	34.4%	₹20 Cr	28.5%	—	—	—
Nureca LimitedNURECANURECA	₹332 Cr	₹333 Cr	₹153 Cr	₹4 Cr	0.1%	₹4 Cr	1.4%	3.3%	1.1%	186
Earkart LtdEARKARTEARKART	₹179 Cr	₹179 Cr	₹54 Cr	₹8 Cr	15.5%	₹5 Cr	9.1%	12.1%	7.7%	243
Choksi Asia LtdCHOKSICHOKSI	₹117 Cr	₹119 Cr	₹11 Cr	₹-2 Cr	13.8%	₹2 Cr	10.8%	18.9%	13.5%	142
Shree Pacetronix LtdSHREEPACSHREEPAC	₹68 Cr	₹71 Cr	₹8 Cr	₹1 Cr	23.5%	₹0 Cr	14%	27.4%	18.9%	385

Laxmi Dental Limited

About

Key insights

Key risks

Growth drivers

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Profit & loss

Balance sheet

Cash flow

Compounded returns

Compounded sales growth

Compounded profit growth

Return on equity

Segment results

Ratios

Ratio timeline

Shareholding

Quarterly record

Bulk & block deals

Board and management

F&O

Not in the F&O segment

Fund holders

Documents

Announcements

Annual reports

Investor Presentation and earnings call

Events

Board meetings1

Announcements

Ratio timeline

Board meetings1

Not in the F&O segment

Announcements

Annual reports

Investor Presentation and earnings call

Quarterly record

Bulk & block deals

Board and management

Profit & loss

Balance sheet

Cash flow

Compounded returns

Compounded sales growth

Compounded profit growth

Return on equity

Segment results

Aligners Business · revenue

1

1